Clonal haematopoiesis of indeterminate potential among cancer survivors exposed to myelotoxic chemotherapy.
作者信息
Olszewski Adam J, Chorzalska Anna D, Kim Annette S, Quesenberry Peter J, Lopresti Mary L, Fenton Mary A, Reagan John L, Butera James N, Sahin Ilyas, Hamel Celine, Robison Jordan, Petersen Max, Dubielecka Patrycja M
机构信息
The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI, USA.
出版信息
Br J Haematol. 2019 Aug;186(3):e31-e35. doi: 10.1111/bjh.15861. Epub 2019 Mar 11.
Abstract
摘要
相似文献
1
Clonal haematopoiesis of indeterminate potential among cancer survivors exposed to myelotoxic chemotherapy.接受骨髓毒性化疗的癌症幸存者中具有不确定潜能的克隆性造血。
Br J Haematol. 2019 Aug;186(3):e31-e35. doi: 10.1111/bjh.15861. Epub 2019 Mar 11.
2
Targeted, Amplicon-Based, Next-Generation Sequencing to Detect Age-Related Clonal Hematopoiesis.基于靶向扩增子的新一代测序技术检测与年龄相关的克隆性造血
Methods Mol Biol. 2019;2045:167-180. doi: 10.1007/7651_2019_216.
3
Connections Between Clonal Hematopoiesis, Cardiovascular Disease, and Cancer: A Review.克隆性造血、心血管疾病和癌症之间的联系：综述。
JAMA Cardiol. 2019 Apr 1;4(4):380-387. doi: 10.1001/jamacardio.2019.0302.
4
Clonal haematopoiesis is not prevalent in survivors of childhood cancer.克隆性造血在儿童癌症幸存者中并不普遍。
Br J Haematol. 2018 May;181(4):537-539. doi: 10.1111/bjh.14630. Epub 2017 Apr 3.
5
Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study.老年患者的克隆性造血与治疗相关的髓系恶性肿瘤：一项概念验证性病例对照研究。
Lancet Oncol. 2017 Jan;18(1):112-121. doi: 10.1016/S1470-2045(16)30627-1. Epub 2016 Dec 4.
6
Identification of Clonal Hematopoiesis Mutations in Solid Tumor Patients Undergoing Unpaired Next-Generation Sequencing Assays.实体瘤患者在接受非配对下一代测序检测时的克隆性造血基因突变的鉴定。
Clin Cancer Res. 2018 Dec 1;24(23):5918-5924. doi: 10.1158/1078-0432.CCR-18-1201. Epub 2018 Jun 4.
7
Cardiovascular Disease, Aging, and Clonal Hematopoiesis.心血管疾病、衰老与克隆性造血
Annu Rev Pathol. 2020 Jan 24;15:419-438. doi: 10.1146/annurev-pathmechdis-012419-032544. Epub 2019 Nov 5.
8
Assessing clonal haematopoiesis: clinical burdens and benefits of diagnosing myelodysplastic syndrome precursor states.评估克隆性造血：诊断骨髓增生异常综合征前驱状态的临床负担与益处
Lancet Haematol. 2020 Jan;7(1):e73-e81. doi: 10.1016/S2352-3026(19)30211-X. Epub 2019 Dec 3.
9
Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study.白血病前期克隆性造血与治疗相关髓系肿瘤的风险：一项病例对照研究。
Lancet Oncol. 2017 Jan;18(1):100-111. doi: 10.1016/S1470-2045(16)30626-X. Epub 2016 Dec 3.
10
Genetic Heterogeneity in Chronic Myeloid Leukemia: How Clonal Hematopoiesis and Clonal Evolution May Influence Prognosis, Treatment Outcome, and Risk of Cardiovascular Events.慢性髓性白血病的遗传异质性：克隆性造血和克隆进化如何影响预后、治疗结果和心血管事件风险。
Clin Lymphoma Myeloma Leuk. 2021 Sep;21(9):573-579. doi: 10.1016/j.clml.2021.04.014. Epub 2021 Apr 29.
引用本文的文献
1
Immune Checkpoint Inhibitor Therapy and Associations with Clonal Hematopoiesis.免疫检查点抑制剂治疗与克隆性造血的关联。
Int J Mol Sci. 2024 Oct 15;25(20):11049. doi: 10.3390/ijms252011049.
2
Impact of cancer therapy on clonal hematopoiesis mutations and subsequent clinical outcomes.癌症治疗对克隆性造血突变及其后续临床结局的影响。
Blood Adv. 2024 Oct 8;8(19):5215-5224. doi: 10.1182/bloodadvances.2024012929.
3
Clonal hematopoiesis in older patients with breast cancer receiving chemotherapy.老年乳腺癌患者接受化疗时的克隆性造血。
J Natl Cancer Inst. 2023 Aug 8;115(8):981-988. doi: 10.1093/jnci/djad065.
4
Clonal hematopoiesis in patients with stem cell mobilization failure: a nested case-control study.患者干细胞动员失败中的克隆性造血：一项巢式病例对照研究。
Blood Adv. 2023 Apr 11;7(7):1269-1278. doi: 10.1182/bloodadvances.2022007497.
5
Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential in Hematology and Cardiovascular Disease.血液学和心血管疾病中不确定潜能克隆性造血的临床意义
Diagnostics (Basel). 2022 Jul 2;12(7):1613. doi: 10.3390/diagnostics12071613.
6
Clonal hematopoiesis: Mutation-specific adaptation to environmental change.克隆性造血：突变特异性适应环境变化。
Cell Stem Cell. 2022 Jun 2;29(6):882-904. doi: 10.1016/j.stem.2022.05.006.
7
Liquid biopsies in pediatric oncology: opportunities and obstacles.儿科肿瘤学中的液体活检：机遇与挑战。
Curr Opin Pediatr. 2022 Feb 1;34(1):39-47. doi: 10.1097/MOP.0000000000001088.
8
Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms.靶向慢性髓性白血病和费城染色体阴性经典骨髓增殖性肿瘤中的异常造血干细胞
Int J Mol Sci. 2021 Jan 11;22(2):659. doi: 10.3390/ijms22020659.
9
Exposure to ibritumomab tiuxetan and incidence of treatment-related myeloid neoplasms among older patients with B-cell lymphoma: a population-based study.老年B细胞淋巴瘤患者接受替伊莫单抗治疗与治疗相关髓系肿瘤的发生率：一项基于人群的研究
Leukemia. 2020 Oct;34(10):2794-2797. doi: 10.1038/s41375-020-0798-9. Epub 2020 Mar 17.
本文引用的文献
1
Detection of clonal hematopoiesis of indeterminate potential in clinical sequencing of solid tumor specimens.实体瘤标本临床测序中不确定潜能克隆性造血的检测
Blood. 2018 May 31;131(22):2501-2505. doi: 10.1182/blood-2018-03-840629. Epub 2018 Apr 20.
2
Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes.非血液系统恶性肿瘤患者治疗相关克隆性造血很常见，并与不良临床结局相关。
Cell Stem Cell. 2017 Sep 7;21(3):374-382.e4. doi: 10.1016/j.stem.2017.07.010. Epub 2017 Aug 10.
3
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma.淋巴瘤自体干细胞移植后与不良预后相关的克隆性造血
J Clin Oncol. 2017 May 10;35(14):1598-1605. doi: 10.1200/JCO.2016.71.6712. Epub 2017 Jan 9.
4
Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study.老年患者的克隆性造血与治疗相关的髓系恶性肿瘤：一项概念验证性病例对照研究。
Lancet Oncol. 2017 Jan;18(1):112-121. doi: 10.1016/S1470-2045(16)30627-1. Epub 2016 Dec 4.
5
Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study.白血病前期克隆性造血与治疗相关髓系肿瘤的风险：一项病例对照研究。
Lancet Oncol. 2017 Jan;18(1):100-111. doi: 10.1016/S1470-2045(16)30626-X. Epub 2016 Dec 3.
6
Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults.携带 AML 相关突变的克隆性造血在健康成年人中普遍存在。
Nat Commun. 2016 Aug 22;7:12484. doi: 10.1038/ncomms12484.
7
Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies.一种用于血液系统恶性肿瘤的定制下一代测序临床检测方法的验证与实施
J Mol Diagn. 2016 Jul;18(4):507-15. doi: 10.1016/j.jmoldx.2016.02.003.
8
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.从血液DNA序列推断克隆性造血与血癌风险。
N Engl J Med. 2014 Dec 25;371(26):2477-87. doi: 10.1056/NEJMoa1409405. Epub 2014 Nov 26.
9
Age-related clonal hematopoiesis associated with adverse outcomes.与不良预后相关的年龄相关性克隆性造血。
N Engl J Med. 2014 Dec 25;371(26):2488-98. doi: 10.1056/NEJMoa1408617. Epub 2014 Nov 26.
10
Age-related mutations associated with clonal hematopoietic expansion and malignancies.与克隆性造血扩张和恶性肿瘤相关的年龄相关突变。
Nat Med. 2014 Dec;20(12):1472-8. doi: 10.1038/nm.3733. Epub 2014 Oct 19.
Zotero 插件